Eribulin in Patients with Liposarcoma and Leiomyosarcoma: A Retrospective Single-Center Experience

INTRODUCTION: Soft tissue sarcomas are rare and heterogenous malignancies with a poor prognosis in advanced disease stages. Eribulin is used in metastatic liposarcoma (LPS) patients, who have failed first-line chemotherapy and has been approved for use in patients with LPS in the USA and Europe due...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinbrecher, Oskar, Brodowicz, Thomas, Raderer, Markus, Scharrer, Anke, Fabsits, Johannes, Lamm, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932822/
https://www.ncbi.nlm.nih.gov/pubmed/36273457
http://dx.doi.org/10.1159/000527632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932822/
https://www.ncbi.nlm.nih.gov/pubmed/36273457
http://dx.doi.org/10.1159/000527632

Ejemplares similares